Who's con­fi­dent­ly in­vest­ing in biotech star­tups dur­ing these tense days? We've got some an­swers

3 years ago
Bioregnum

As­traZeneca gives up on late-stage IL-23 drug due to tri­al de­lays, com­pet­i­tive land­scape

3 years ago
R&D

FDA ap­proves As­traZeneca's Lyn­parza com­bo for adults with BR­CA-mu­tat­ed prostate can­cer

3 years ago
R&D

Ex­clu­sive: With $8M, neu­ro start­up Mod­u­lo Bio emerges to test small mol­e­cules for ALS, de­men­tia in CEO’s per­son­al ...

3 years ago
Financing
Startups

FDA ap­proves Pfiz­er’s RSV shot for old­er adults, tee­ing up a com­pet­i­tive $17B vac­cine mar­ket

3 years ago
Pharma
FDA+

FDA's can­cer chief weighs in on com­mon chemo short­ages — re­port

3 years ago
Pharma
FDA+

NICE rec­om­mends Pfiz­er's mi­graine drug for use in the UK, with some re­stric­tions

3 years ago
Pharma

Yuhan Cor­po­ra­tion to pay $325M to in-li­cense pre­clin­i­cal HER2 can­di­date

3 years ago
Deals
Pharma

Can­cer as­so­ci­a­tion says na­tion­al bud­get deal threat­ens re­search fund­ing

3 years ago
Pharma

FDA warns about com­pound­ed semaglu­tide-based drugs

3 years ago
Pharma
FDA+

FDA in­spec­tion of Chi­na-based site mak­ing Co­herus' po­ten­tial new can­cer drug ends with three ob­ser­va­tions

3 years ago
China
FDA+

PBM as­so­ci­a­tion launch­es ad cam­paign push­ing back on drug­mak­er­s' lob­by­ing ‘pow­er’ amid con­gres­sion­al pres­sure

3 years ago
Pharma
Marketing

Pre­ci­sion Bio­Sciences to meet with FDA af­ter tout­ing al­lo­gene­ic CAR-T win

3 years ago
R&D
Cell/Gene Tx

Seres re­ceives $125M pay­ment from Nestlé; French biotech teas­es ear­ly-stage eye dis­ease da­ta

3 years ago
News Briefing

Vi­o­let Ther­a­peu­tics snags $10.6M in seed fund­ing for plat­forms that go be­yond sin­gle-cell se­quenc­ing

3 years ago
R&D

MEI Phar­ma re­ceives un­so­licit­ed of­fer as it pro­ceeds with In­fin­i­ty merg­er

3 years ago
Deals

Clin­i­cal hold for Pep­Gen's my­oton­ic dy­s­tro­phy pro­gram halts march to the clin­ic

3 years ago
FDA+

Glyscend Ther­a­peu­tic­s' ear­ly da­ta show poly­mer mim­ics ben­e­fits of surgery in type 2 di­a­betes, obe­si­ty

3 years ago
R&D

RA Cap­i­tal-backed non-vi­ral gene ther­a­py start­up Sum­ma­tion Bio to shut down

3 years ago
People
Cell/Gene Tx

Sanofi rolls out PhII mul­ti­ple scle­ro­sis da­ta that will take the phar­ma in­to piv­otal stud­ies next year

3 years ago
R&D
Pharma

Al­ny­lam files a new set of law­suits against Mod­er­na and Pfiz­er over Covid-19 vac­cines

3 years ago
Pharma
Law

FDA in­spec­tion of UCB fa­cil­i­ty in Bel­gium finds sev­er­al qual­i­ty is­sues

3 years ago
FDA+
Manufacturing

A decade in the mak­ing: FDA pro­pos­es new, easy-to-read pa­tient med­ica­tion guide

3 years ago
FDA+

Eli Lil­ly set­tles in­sulin pric­ing law­suit for $13.5M, month­ly out-of-pock­et com­mit­ment

3 years ago
Pharma
FDA+
First page Previous page 334335336337338339340 Next page Last page
A service from the Financial Times